Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06298357 · ClinicalTrials.gov registry record · Phase 1
Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
A Phase 1 study of Pediatric Cancer, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT06298357: Completed Phase 1 study of Pediatric Cancer, sponsored by University of Alabama at Birmingham.
NCT06298357 is a Phase 1 study of Pediatric Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 11 participants, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06298357, a Phase 1 study of Pediatric Cancer, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will explore the potential benefits of a virtual reality gaming program that focuses on mindfulness and exercise among pediatric cancer rehabilitation patients. The program will last 8 weeks outside of the hospital. Participants will start immediately in the hospital (immediate start group) or wait 8 weeks after hospital discharge to start the program (waitlist control group).
Primary Outcome
Steps per day measured by a tri-axial accelerometer (Fitbit Flex).
Conditions Studied
Interventions
- BEHAVIORAL Immediate Start - Virtual Reality
- BEHAVIORAL Delayed Start - Virtual Reality
Study Locations (1)
Alabama
- Children's Hospital of Alabama - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-06-27 |
| Est. Completion | 2026-03-16 |
| Phase | Phase 1 |
What the finished NCT06298357 record still lists
NCT06298357 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 2 interventions - of which Immediate Start - Virtual Reality is the first listed.
NCT06298357 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06298357 about?
NCT06298357 is a clinical study titled "Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation". This study will explore the potential benefits of a virtual reality gaming program that focuses on mindfulness and exercise among pediatric cancer rehabilitation patients. The program will last 8 weeks outside of the hospital. Participants will start immediately in the hospital (immediate start grou...
What is the current status of trial NCT06298357?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2024-06-27. Estimated completion is 2026-03-16.
What conditions does trial NCT06298357 study?
This clinical trial studies the following conditions: Pediatric Cancer.
What interventions are being tested in trial NCT06298357?
The interventions under investigation include: Immediate Start - Virtual Reality (BEHAVIORAL), Delayed Start - Virtual Reality (BEHAVIORAL).
Who is sponsoring clinical trial NCT06298357?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06298357 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06298357's enrollment target sits among peer trials
11 50th of 51 higher than 2 of 51 other Pediatric Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
RECRUITING · Phase 1
-
Lurbinectedin in FET-Fused Tumors
RECRUITING · Phase 1
-
Durvalumab and Tremelimumab for Pediatric Malignancies
ACTIVE NOT RECRUITING · Phase 1
-
LIFE Cancer Survivorship Database for Pediatric Cancer
RECRUITING
-
Multisite Implementation of COMPRENDO
RECRUITING · NA
-
Childhood Cancer Predisposition Study (CCPS)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI